Zanaflex Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Zanaflex General Information

Description

Zanaflex is an essential compound useful in treating serious illnesses. It will be used to produce capsules or tablets for the treatment of spinal cord injuries or multiple sclerosis as well as brain injuries and strokes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Acorda Therapeutics
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zanaflex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zanaflex‘s full profile, request access.

Request a free trial